at CNBC.com (Sep 25, 2014)
LipoScience (LPDX) cuts its IPO range to $9-10 from $13-15. At 5M shares, that will be about $48M raised for the medical diagnostic firm whose nuclear magnetic resonance (NMR) LipoProfile test provides risk assessment for cardiovascular events.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs